MKI67 and breast adenocarcinoma: Immunohistochemistry was used to compare relative expression levels of the hormone receptors ERα and PgR, cyclin D1, Ki67 and ErbB2 in the mammary adenocarcinomas that developed in the different genotypes across treatment groups.